PHARMACEUTICAL MANAGEMENT
Year : 2009  |  Volume : 1  |  Issue : 1  |  Page : 86-89

Prophylaxis in migraine management


Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham University, AIMS Healthcare Campus, AIMS Ponekkara (P.O), Kochi, Kerala - 682 041, India

Correspondence Address:
M Sonal Sekhar
Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham University, AIMS Healthcare Campus, AIMS Ponekkara (P.O), Kochi, Kerala - 682 041
India
Login to access the Email id


DOI: 10.4103/0975-1483.51877

Get Permissions

A migraine is the most common cause of severe, recurring headache. With the recent advances in our understanding of migraine, it can be effectively treated and even prevented. Prophylactic treatment of migraines is indicated when patients have three or more severe migraine attacks a month that interfere with quality of life or when attacks are prolonged and symptomatic medication used alone is not satisfactory. The major objective of migraine prophylactic therapy is optimizing the patient's ability to function normally by reducing the frequency, duration, and intensity of attacks. The major migraine preventive therapies include β-blockers, calcium-channel blockers, and tricyclic medications. Preventive treatment should be tailored to individual patient needs. This requires that patient and healthcare professionals understand the rationale and participate actively in decisions regarding therapeutic intervention.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1593    
    Printed117    
    Emailed2    
    PDF Downloaded168    
    Comments [Add]    
    Cited by others 1    

Recommend this journal